Lista de obras -

A second case of the acquired immunodeficiency syndrome due to human immunodeficiency virus type 2 in the United States: the clinical implications

artículo científico publicado en 1989

APOBEC3G complexes decrease human immunodeficiency virus type 1 production

artículo científico

APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo ⬇️

artículo científico publicado el 12 de mayo de 2012

Accuracy of the TRUGENE HIV-1 genotyping kit.

artículo científico publicado en 2003

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

artículo científico publicado en 2003

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity

artículo científico publicado en 2002

Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection ⬇️

artículo científico publicado el 2 de mayo de 2003

Antiretroviral resistance during successful therapy of HIV type 1 infection.

artículo científico publicado en 2000

Antiretroviral resistance testing for clinical management.

artículo científico publicado en 2002

Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testing

artículo científico publicado en 2000

Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

artículo científico publicado en 2001

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

artículo científico publicado en 2003

Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase

artículo científico publicado en 2000

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

artículo científico publicado en 2003

Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report

artículo científico publicado en 2014

Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells

artículo científico publicado en 2009

Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity

artículo científico publicado en 2009

Drug resistance mutations in HIV-1.

artículo científico publicado en 2003

Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection.

artículo científico publicado en 2003

Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU)

artículo científico publicado en 1987

Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).

artículo científico publicado en 2014

Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly

artículo científico publicado en 2011

Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores

artículo científico publicado en 2014

Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load

artículo científico publicado en 2010

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

artículo científico publicado en 2001

HIV infection in intravenous drug abusers

scientific article published on 01 January 1987

HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077

artículo científico publicado en 2014

HIV-1 chemotherapy and drug resistance

artículo científico publicado en 1995

Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing

artículo científico publicado en 1999

Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study

artículo científico publicado en 2006

Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures

artículo científico publicado en 2008

Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

artículo científico publicado en 2001

Limits of resistance testing

artículo científico publicado en 2000

Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo

artículo científico publicado en 2013

Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users

artículo científico publicado el 1 de enero de 1992

Molecular cloning and characterization of Na,K-ATPase from Hydra vulgaris: implications for enzyme evolution and ouabain sensitivity.

artículo científico publicado en 1992

Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study

artículo científico publicado en 2006

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy

artículo científico publicado en 2012

Oxidant stress is increased during treatment of human immunodeficiency virus infection

artículo científico publicado en 2003

Persistent Genital Tract HIV-1 RNA Shedding After Change in Treatment Regimens in Antiretroviral-Experienced Women with Detectable Plasma Viral Load ⬇️

artículo científico publicado el 26 de marzo de 2013

Phospholipase D1 Couples CD4+ T Cell Activation to c-Myc-Dependent Deoxyribonucleotide Pool Expansion and HIV-1 Replication

artículo científico publicado en 2015

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

artículo científico publicado en 1999

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

artículo científico publicado en 2010

Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.

artículo científico publicado en 2017

Prevalence of HTLV-III infection among New Haven, Connecticut, parenteral drug abusers in 1982-1983.

artículo científico publicado en 1986

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy

artículo científico publicado en 2002

Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users

artículo científico publicado en 1989

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites

artículo científico publicado en 2000

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

artículo científico publicado en 1994

Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial

artículo científico publicado en 2012

Signals in APOBEC3F N-terminal and C-terminal Deaminase Domains Each Contribute to Encapsidation in HIV-1 Virions and Are Both Required for HIV-1 Restriction ⬇️

artículo científico publicado el 28 de marzo de 2012

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

artículo científico publicado en 1993

Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.

artículo científico publicado en 2004

Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals

artículo científico publicado en 2008

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation

artículo científico publicado en 2008

The protease inhibitor ritonavir inhibits the functional activity of the multidrug resistance related-protein 1 (MRP-1).

artículo científico publicado en 2002

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.

artículo científico publicado en 2000

The role of dopamine in the mechanism of action of antidepressant drugs

artículo científico publicado en 2000

The safe patient flow initiative: a collaborative quality improvement journey at Yale-New Haven Hospital

artículo científico

Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.

artículo científico publicado en 1999

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro ⬇️

artículo científico publicado el 1 de octubre de 1991

Update of the drug resistance mutations in HIV-1: 2004.

artículo científico publicado en 2004

Yale-New Haven Hospital's Planning and Execution of a Complex Hospital Acquisition ⬇️

artículo científico publicado el 1 de agosto de 2013

pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo

artículo científico publicado en 1993

Lista de obras de

A second case of the acquired immunodeficiency syndrome due to human immunodeficiency virus type 2 in the United States: the clinical implications

APOBEC3G complexes decrease human immunodeficiency virus type 1 production

APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo ⬇️

Accuracy of the TRUGENE HIV-1 genotyping kit.

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity

Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection ⬇️

Antiretroviral resistance during successful therapy of HIV type 1 infection.

Antiretroviral resistance testing for clinical management.

Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testing

Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report

Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells

Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity

Drug resistance mutations in HIV-1.

Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection.

Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU)

Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).

Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly

Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores

Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

HIV infection in intravenous drug abusers

HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077

HIV-1 chemotherapy and drug resistance

Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing

Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study

Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures

Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

Limits of resistance testing

Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo

Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users

Molecular cloning and characterization of Na,K-ATPase from Hydra vulgaris: implications for enzyme evolution and ouabain sensitivity.

Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy

Oxidant stress is increased during treatment of human immunodeficiency virus infection

Persistent Genital Tract HIV-1 RNA Shedding After Change in Treatment Regimens in Antiretroviral-Experienced Women with Detectable Plasma Viral Load ⬇️

Phospholipase D1 Couples CD4+ T Cell Activation to c-Myc-Dependent Deoxyribonucleotide Pool Expansion and HIV-1 Replication

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.

Prevalence of HTLV-III infection among New Haven, Connecticut, parenteral drug abusers in 1982-1983.

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy

Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial

Signals in APOBEC3F N-terminal and C-terminal Deaminase Domains Each Contribute to Encapsidation in HIV-1 Virions and Are Both Required for HIV-1 Restriction ⬇️

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.

Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation

The protease inhibitor ritonavir inhibits the functional activity of the multidrug resistance related-protein 1 (MRP-1).

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.

The role of dopamine in the mechanism of action of antidepressant drugs

The safe patient flow initiative: a collaborative quality improvement journey at Yale-New Haven Hospital

Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro ⬇️

Update of the drug resistance mutations in HIV-1: 2004.

Yale-New Haven Hospital's Planning and Execution of a Complex Hospital Acquisition ⬇️

pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo